Characterization of Skin Changes (Clinical, Physiological and Pathological) Leading to Dermatological Adverse Events From Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immune Checkpoint Inhibitors

Summary

The goal of this clinical trial is to evaluate whether cosmeceutical topical moisturizers can help with skin dryness in participants with cancer experiencing a dermatological adverse event from cancer therapies. The main question it aims to answer is: Does cosmeceutical topical moisturizers help with skin dryness? Participants will: * Visit the clinic for a baseline visit to complete skin evaluation and tests. * Apply cosmeceutical topical moisturizers daily from baseline up until the follow-up visit. * Visit the clinic for a follow-up visit (approximately 2-4 weeks from baseline) for a repeat skin evaluation and tests.

Eligibility

Age range

18+ years

Sex

All

Healthy volunteers

No

Interventions

• Other
  La Roche Posay Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash

  Moisturizer wash applied once in the morning and once in the evening.

• Other
  La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream

  Moisturizer applied once in the morning and once in the evening.

• Other
  La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+)

  Balm applied once in the morning and once in the evening.

Location